Overexpression of Serum Amyloid A-Activating Factor 1 Inhibits Cell Proliferation by the Induction of Cyclin-Dependent Protein Kinase Inhibitor p21WAF/Cip-1/Sdi-1 Expression

Journal of Immunology

Volumn 172, Issue 8, 2004, Pages 5006-5015

  Ray, Alpana ^a   Shakya, Arvind ^a   Kumar, Deepak ^a   Ray, Bimal K ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CYCLIN DEPENDENT KINASE; PROTEIN P21; SERUM AMYLOID A; SERUM AMYLOID A ACTIVATING FACTOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DNA SYNTHESIS; FIBROBLAST; GENE OVEREXPRESSION; GROWTH INHIBITION; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN INDUCTION; RABBIT; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; TRANSCRIPTION REGULATION;

EID: 1842581657     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.8.5006     Document Type: Article

References (41)

1. Firestein, G. S., and A. M. Manning. 1999. Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum. 42:609.
2. Firestein, G. S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423:356.
3. Ray, A., K. Kuroki, J. L. Cook, B. S. Bal, K. Kenter, G. Aust, and B. K. Ray. 2003. Induction of matrix metalloproteinase 1 gene expression is regulated by infixnmation-responsive transcription factor SAF-1 in osteoarthritis. Arthritis Rheum. 48:134.
4. Bossone, S. A., C. Asselin, A. J. Patel, and K. B. Marcu. 1992. MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. Proc. Natl. Acad. Sci. USA 89:7452.
5. Kennedy, G. C., and W. J. Rutter. 1992. Pur-1, a zinc-finger protein that binds to purine-rich sequences, transactivates an insulin promoter in heterologous cells. Proc. Natl. Acad. Sci. USA 89:11498.
6. Parks, C. L., and T. Shenk. 1997. Activation of the adenovirus major late promoter by transcription factors MAZ and Sp1. J. Virol. 71:9600.
7. Parks, C. L., and T. Shenk. 1996. The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1. J. Biol. Chem. 271:4417.
8. Ray, A., and B. K. Ray. 1998. Isolation and functional characterization of cDNA of serum amyloid A-activating factor that binds to the serum amyloid A promoter. Mol. Cell Biol. 18:7327.
9. Duncan, D. D., A. Stupakoff, S. M. Hedrick, K. B. Marcu, and G. Siu. 1995. A Myc-associated zinc finger protein binding site is one of four important functional regions in the CD4 promoter. Mol. Cell. Biol. 15:3179.
10. Ray, A. 2000. A SAF binding site in the promoter region of human γ-fibrinogen gene functions as an IL-6 response element. J. Immunol. 165:3411.
11. Ray, B. K., R. Murphy, P. Ray, and A. Ray. 2002. SAF-2, a splice variant of SAF-1, acts as a negative regulator of transcription. J. Biol. Chem. 277:46822.
12. Ray, A., and B. K. Ray. 1999. Persistent expression of serum amyloid A during experimentally induced chronic inflammatory condition in rabbit involves differential activation of SAF. NF-κB, and C/EBP transcription factors. J. Immunol. 163:2143.
13. Cross, F., J. Roberts, and H. Weintraub. 1989. Simple and complex cell cycles. Annu. Rev. Cell Biol. 5:341.
14. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323.
15. Flemington, E. K., S. H. Speck, and W. G. Kaelin, Jr. 1993. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 90:6914.
16. Weintraub, S. J., K. N. Chow, R. X. Luo, S. H. Zhang, S. He, and D. C. Dean. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375:812.
17. 1 phase progression: cycling on cue. Cell 79:551.
18. el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817.
19. Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90.
20. 1 cyclin-dependent kinases. Cell 75:805.
21. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701.
22. Zhang, H., Y. Xiong, and D. Beach. 1993. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell 4:897.
23. Harper, J. W., and S. J. Elledge. 1996. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6:56.
24. Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L. H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, et al. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387.
25. Datto, M. B., Y. Yu, and X. F. Wang. 1995. Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270:28623.
26. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018.
27. Biggs, J. R., J. E. Kudlow, and A. S. Kraft. 1996. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J. Biol. Chem. 271:901.
28. Luckow, B., and G. Schutz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490.
29. Ray, A., G. Y. Yu, and B. K. Ray. 2002. Cytokine-responsive induction of SAF-1 activity is mediated by a mitogen-activated protein kinase signaling pathway. Mol. Cell. Biol. 22:1027.
30. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
31. Ray, B. K., and A. Ray. 1997. Involvement of an SAF-like transcription factor in the activation of serum amyloid A gene in monocyte/macrophage cells by lipopolysaccharide. Biochemistry 36:4662.
32. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
33. Ray, A., and B. K. Ray. 1996. A novel cis-acting element is essential for cytokine-mediated transcriptional induction of the serum amyloid A gene in nonhepatic cells. Mol. Cell. Biol. 16:1584.
34. Ray, A., and B. K. Ray. 1993. Analysis of the promoter element of the serum amyloid A gene and its interaction with constitutive and inducible nuclear factors from rabbit liver. Gene Exp. 3:151.
35. Ray, A., H. Schatten, and B. K. Ray. 1999. Activation of Sp1 and its functional co-operation with serum amyloid A-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression. J. Biol. Chem. 274:4300.
36. 1-phase growth-arresting action of interleukin-I is independent of p53 and p21/WAF1 function. J. Biol. Chem. 273:30517.
37. Bellido, T., C. A. O'Brien, P. K. Roberson, and S. C. Manolagas. 1998. Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines: a prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J. Biol. Chem. 273:21137.
38. Adnane, J., F. A. Bizouarn, Y. Qian, A. D. Hamilton, and S. M. Sebti. 1998. p21(WAF1/CIP1) is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor β- and Sp1-responsive element: involvement of the small GTPase rhoA. Mol. Cell. Biol. 18:6962.
39. Taniguchi, K., H. Kohsaka, N. Inoue, Y. Terada, H. Ito, K. Hirokawa, and N. Miyasaka. 1999. Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nat. Med. 5:760.
40. Nasu, K., H. Kohsaka, Y. Nonomura, Y. Terada, H. Ito, K. Hirokawa, and N. Miyasaka. 2000. Adenoviral transfer of cyclin-dependent kinase inhibitor genes suppresses collagen-induced arthritis in mice. J. Immunol. 165:7246.
41. Perlman, H., K. Bradley, H. Liu, S. Cole, E. Shamiyeh, R. C. Smith, K. Walsh, S. Fiore, A. E. Koch, G. S. Firestein, et al. 2003. IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts. J. Immunol. 170:838.